FundedIQ
Biotechnology

Summit Therapeutics: Funding, Investors & Team (Sep 2026)

Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.

www.summitplc.com LinkedIn Abingdon, United Kingdom 101-250 employees
Biotechnology Health Care Medical Device Therapeutics
Total raised
$75.0M
Rounds
1
Latest
Undisclosed round
May 2021

Summit Therapeutics has raised $75.0M across 1 funding round on record, the most recent an undisclosed round of $75.0M announced in May 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Summit Therapeutics Company Profile and Key Stats

Total funding raised
$75.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$75.0M in May 2021
Employees
101-250
reported band
Headquarters
Abingdon, United Kingdom

Latest funding round on record: May 2021.

Summit Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$75.0M

Summit Therapeutics Founders and Leadership Team

Name
Role
Contact
Bob Duggan
CEO
Locked

Contact details for the Summit Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Summit Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
5,273
$4.0M

Summit Therapeutics' latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Summit Therapeutics in Biotechnology and Abingdon

Companies Similar to Summit Therapeutics

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

Summit Therapeutics Funding FAQs

What does Summit Therapeutics do?

Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.

How much funding has Summit Therapeutics raised?

Summit Therapeutics has raised $75.0M across 1 round on record. The most recent is an undisclosed round of $75.0M announced in May 2021.

When did Summit Therapeutics last raise funding?

Summit Therapeutics' most recent funding round on record is an undisclosed round of $75.0M, announced in May 2021.

Who is the CEO of Summit Therapeutics?

Bob Duggan is listed as CEO at Summit Therapeutics.

Where is Summit Therapeutics headquartered?

Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom.

How many employees does Summit Therapeutics have?

Summit Therapeutics is in the 101-250 employee band.

How does Summit Therapeutics' funding compare to other Biotechnology startups?

Summit Therapeutics' latest round of $75.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Summit Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Summit Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.